Abstract: A method for treating a hypophosphatemic bone disease, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition, which contains an antibody that binds to an FGF-23 polypeptide and a pharmaceutically acceptable carrier.

Abstract: The present invention provides a sample measuring device capable of allowing not only one but more than one kind of samples to react with a reagent, and enhancing a reliability in photometric analysis accuracy by reliably mixing and agitating the sample and the reagent prior to the photometric analysis. The device includes a reagent melting/mixing means, a sample supply chamber positioned on the upstream side of, and communicating with, the reagent melting/mixing means when the sample is allowed to flow into the reagent melting/mixing means, and at least one measuring chamber positioned on the downstream side of, and communicating with, the reagent melting/mixing means, wherein the sample supply chamber, the reagent melting/mixing means, and the measuring chamber are arranged sequentially from the upstream to the downstream directions of the flow passage, with the sample supply chamber positioned on the upstream side with respect to the sample flow by a sample moving means.

Abstract: A DNA, which encodes the following polypeptide (a), (b), (c) or (d): (a) a polypeptide consisting of an amino acid sequence represented by SEQ ID NO: 2 or 4, (b) a polypeptide consisting of an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO: 2 or 4 by deletion, substitution or addition of one or several amino acids, and having hypophosphatemia-inducing activity, phosphate transport-suppressing activity, calcification-suppressing activity or in vivo vitamin D metabolism-regulating activity, (c) a polypeptide consisting of a partial sequence of the amino acid sequence represented by SEQ ID NO: 2, wherein the above partial sequence contains an amino acid sequence at least ranging from the 34th to 201st amino acids in the above amino acid sequence, or (d) a polypeptide consisting of a partial sequence of the amino acid sequence represented by SEQ ID NO: 2, wherein the above partial sequence: (i) contains an amino acid sequence ranging from at least the 34th to 201st amino aci

Abstract: The present invention provides the following [1] to [3], etc.

Abstract: A DNA, which encodes the following polypeptide (a), (b), (c) or (d):

Abstract: A method for avoiding influence of hemoglobin, in which the influence is caused by the changes with time in the absorption wavelength of hemoglobin when light absorption of a color reaction of a sample is measured by a rate assay, wherein the method comprises measuring the light absorption at a wavelength of from 517 to 529 nm or from 580 to 592 nm.

Abstract: Human hepatoma-derived cell line FLC-4 (deposited with the National Institute of Bioscience and Human-Technology, the Agency of Industrial Science and Technology under Accession Number FERM BP-5165), as well as a method for large-scale production of albumin by culturing the cell line with a radial-flow type bioreactor are provided.

Abstract: A bioreactor comprises a cylindrical tank, a cylindrical mesh member arranged inside the tank concentrically therewith so that the mesh member separates an inner space of the tank into an outside space defined between an inner wall of the tank and the mesh member and an inside space, these spaces being packed with a culture medium or a carrier, respectively, a plurality of oxygen supplying pipes extending axially inside or outside the mesh member for supplying an oxygen to the culture medium, culture medium supplying assembly for supplying the culture medium in the tank, and a plurality of culture medium recovery pipes extending axially inside or outside the mesh member for recovering the culture medium after utilized. The culture medium supplying assembly comprises a plurality of nozzle members which are arranged in the outside space described above or inside the mesh member so that the culture medium supplied through the nozzle members can flow radially inwardly or radially outwardly.